Ciusss de L'Est de l'Île de Montréal
Quick facts
Marketed products
- bolus of intravenous ketamine · Anesthesia, Analgesia, Psychiatry
Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor that produces rapid-onset anesthesia and analgesia. - Bupivacaine Injection · Anesthesia
Bupivacaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia. - Carbetocin bolus · Obstetrics
Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote hemostasis. - Carbetocin infusion · Obstetrics/Gynecology
Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown. - continuous infusion of intravenous ketamine · Anesthesia, Pain Management, Psychiatry
Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor that blocks glutamate signaling in the central nervous system. - Intravenous Fentanyl guided by SoC · Pain management, Anesthesia
Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation. - Intravenous Fentanyl guided by SoC+NOL · Anesthesia and Pain Management
Intravenous fentanyl is a potent opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation, with dosing guided by real-time monitoring of the nociceptive level (NOL index) combined with standard of care (SoC) assessment. - intravenous lidocaine (IVL) · Cardiovascular; Anesthesia; Pain management
Intravenous lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Phase 2 pipeline
- Lenalidomide-Dexamethasone-DLI · Oncology
Lenalidomide is an immunomodulatory drug that targets the ubiquitin-proteasome pathway, and Dexamethasone is a corticosteroid that modulates the immune response. DLI (Donor Lymphocyte Infusion) is a form of immunotherapy that involves infusing donor lymphocytes to treat hematologic malignancies.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Ciusss de L'Est de l'Île de Montréal portfolio CI brief
- Ciusss de L'Est de l'Île de Montréal pipeline updates RSS
Frequently asked questions about Ciusss de L'Est de l'Île de Montréal
What are Ciusss de L'Est de l'Île de Montréal's marketed drugs?
Top marketed products include bolus of intravenous ketamine, Bupivacaine Injection, Carbetocin bolus, Carbetocin infusion, continuous infusion of intravenous ketamine, Intravenous Fentanyl guided by SoC.
Related
- bolus of intravenous ketamine · Anesthesia, Analgesia, Psychiatry
- Bupivacaine Injection · Anesthesia
- Carbetocin bolus · Obstetrics
- Carbetocin infusion · Obstetrics/Gynecology
- continuous infusion of intravenous ketamine · Anesthesia, Pain Management, Psychiatry
- Sector hub: All tracked pharma companies